课题基金 / 基金详情

Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathy

Study on the mechanism by which apolipoprotein(apo) E2 promotes diabetic nephropathy
载脂蛋白(apo)E2促进糖尿病肾病的机制研究
批准号:
14571112
负责人:
ETO Masaaki
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

ETO Masaaki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Background and Aim : In 1994 we first demonstrated that the apolipoprotein(apo) E ε2 allele is associated with the progression of diabetic nephropathy. Apo E2 is well known to contribute to high plasma levels of remnant lipoproteins. The aim of the present study is to further investigate the association between apo E genetic polymorphism, remnant lipoproteins and diabetic nephropathy.Subjects and Methods : Type 2 diabetic patients who had a diabetes duration over 10 years were divided into the 3 apo E groups ; apo E2(n=22),E3/3(n=102) and E4(n=34). Plasma levels of lipids and remnant lipoproteins were measured. Histologic studies were performed using renal biopsy specimens in apo E2 patient. The effects of apo E2-IDL(remnant lipoproteins) on cultured human mesangial cells were studied.Results : The frequency of overt nephropathy was significantly higher in apo E2 diabetic patients(59.1%) than in apo E3/3(34.3%) or apo E4 patients(8.8%), and there was also a significant difference in the frequency of overt nephropathy between apo E3/3 and E4 groups. Plasma levels of triglyceride and remnant-like lipoprotein particles(RLP)-chol and were significantly higher in apo E2 patients, and significantly lower in apo E4 patients than in apo E3/3 patients. Logistical regression analysis showed that odds ratios of high plasma remnant(RLP-C≧5.2mg/dl) for the presence of overt nephropathy were 3.614(p=0.0208). Histological renal change of apo E2 patient was almost identical to diabetic nephropathy. Immunohistochemically, apo E and apo B were stained in glomerulus of apo E2 patient. Apo E2-IDL stimulated significantly PKC activity, TGF-b synthesis, and type IV collagen and fibronectin synthesis in mesangial cells sa compared with apo E3/3-IDL.Conclusion : Remnant lipoproteins may have an important role in the progression of diabetic nephropathy.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
Saito M, Eto M, Nitta H, et al.: "Effect of apolipoprotein E4 allele on plasma LDL-cnolesterol response to diet therapy in type 2 diabetic patients"Diabetes Care. (In press).
Saito M、Eto M、Nitta H 等人:“载脂蛋白 E4 等位基因对 2 型糖尿病患者饮食疗法对血浆 LDL-胆固醇反应的影响”糖尿病护理。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hamano M, Saito M, Eto M et al.: "Serum amyloid A (SAA), C-reactive protein (CRP) and remnant-like lipoprotein particles (RLP)-cholesterol in type 2 diabetic patients with coronary heart disease"Ann Clin Biochem. (In press).
Hamano M、Saito M、Eto M 等人:“患有冠心病的 2 型糖尿病患者的血清淀粉样蛋白 A (SAA)、C 反应蛋白 (CRP) 和残余样脂蛋白颗粒 (RLP)-胆固醇”Ann Clin
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eto M, Saito M, Nakata H: "Type III hyperlipoproteinemia with apolipoprotein E2/2 genotype in Japan"Clinical Genetics. 61. 416-422 (2002)
Eto M、Saito M、Nakata H:“日本载脂蛋白 E2/2 基因型的 III 型高脂蛋白血症”临床遗传学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Eto M, Saito M, Okada M, Kume Y, Kawasaki F, Matsuda M, Yoneda M, Matsuki M, Takigami S, Kaku K.: "Apolipoprotein E genetic polymorphism, remanat lipoproteins and nephropathy in type 2 diabetic patients."Am J Kidney Dis. 40. 243-251 (2002)
Eto M、Saito M、Okada M、Kume Y、Kawasaki F、Matsuda M、Yoneda M、Matsuki M、Takigami S、Kaku K.:“载脂蛋白 E 遗传多态性、残余脂蛋白和 2 型糖尿病患者的肾病。”Am J
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
14
    Risk factors for diabetic nephropathy (apolipoprotein E2 allele and remnant lipoproteins) and drug intervention
    • 批准号:
      19590155
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.66万
    • 财政年份:
      2007
    • 负责人:
      ETO Masaaki
    • 依托单位:
    Diabetic nephropathy and apolipoprotein E2 allele
    • 批准号:
      12671128
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.6万
    • 财政年份:
      2000
    • 负责人:
      ETO Masaaki
    • 依托单位:
    Study on the significance of apo E in aherosclerosis
    • 批准号:
      05670407
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1993
    • 负责人:
      ETO Masaaki
    • 依托单位: